As much as I try to telework to minimize our firm’s environmental footprint, there are times when I just have to travel to meet client needs. So I fly. A lot. I can, like most frequent flyers, recite the safety briefing from memory. On a recent trip, it occurred to me there are gems of wisdom in that briefing that we can apply to the world of corporate responsibility, if we look at them creatively.
Remember when the iPad came out? People didn’t really know what it was. As in, many thought it was a replacement for a computer. Others thought, no, it was like a really big phone. No one was really clear as to its uses and many continually tried to put it in categories they were familiar with.
Imagine if buying a book from Amazon required you to first visit Amazon.com, followed by a phone call to arrange a meeting to pick up and pay for the book, followed by a visit to a separate website to get suggestions on other books and provide a review of the book and transaction. It sounds ridiculous. Fortunately for us, Amazon.com has taken great care to create a single, consistent digital experience on one website from start to finish.
Twitter is a wonderfully accessible and democratising platform that lends itself perfectly to engaging in CSR and Sustainability stakeholder conversations. The audience of available agenda related professionals, brands, NGOs and enthusiasts is breath-taking in scope and also accessibility.
Zoe Dunn, principal of Hale Advisors, says that Pharma companies can find better ways to communicate with nurse practitioners and physicians assistants. “These important healthcare professionals receive very little time and energy from the pharmaceutical industry, yet they are prescribers in most states and of most medication, and more often than not, spend much more time with patients than doctors,” says Dunn. “They need patient education materials, updates on research and insights, and a voice in achieving better health outcomes. We need to hear from them as well.
LinkedIn Groups are an often overlooked tool to build expertise, position brands and increase audience reach for companies and individuals alike. We thought we would share some learning and tips from our experience so far:
Well, it’s been a disappointing conclusion to the year from a Pharma perspective: Plan B doesn’t work if you weigh more than 175 pounds, lowering LDL isn’t as effective as we thought, and the FDA is coming down on 23 & Me, shuttering it until it completes a medical device application. What all this says to me is that with innovation comes risk: risk that you might not succeed, and risk that raising the bar might increase your level of scrutiny. It doesn’t rain on my parade, though – we keep pushing for innovation at every turn.
Now that the U.S. Food & Drug Administration (FDA) has issued its final guidance on how it will regulate health-related smartphone applications, the marketing and developer community have heaved a collective sigh of relief.